Achira is developing atomistic foundation simulation models intended to advance drug discovery. The company's work sits at the intersection of machine learning, quantum chemistry, physics, and statistical mechanics, applying these disciplines to biomolecular problems.
Its core product consists of advanced potentials and generative models that combine geometric deep learning with principles from quantum chemistry and statistical mechanics. These models are designed for applications in computer-aided drug discovery, aiming to simulate molecular behaviour at the atomic level.
The team comprises machine learners, quantum chemists, engineers, and computer-aided drug discovery practitioners. They share the stated goal of creating a fundamentally new approach to discovering therapeutic compounds.
